DMII
Drugs Made In America Acquisition II Corp.
10.20$
+0.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 11.0% | 10.2% | 0.2% | 0.0% | 0.1% | 0.0% | |
| – | 6.7% | 3.9% | 0.1% | 0.0% | 0.1% | 0.0% | |
| – | 6.7% | 3.9% | 0.1% | – | 0.1% | 0.0% | |
| – | – | 2.3% | 0.1% | – | – | – | |
| – | 267.5% | 288.8% | 3.6% | 3.5% | 3.6% | 3.5% | |
| – | 267.5% | 288.8% | 0.1% | 0.1% | 0.1% | 0.1% | |
| – | 238.0% | 262.2% | – | – | 0.1% | 0.1% | |
| – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | -167.5% | -188.8% | 96.4% | 96.5% | 96.4% | 96.5% | |
| – | -200.8% | -219.7% | -3.4% | -3.5% | -3.5% | -3.5% | |
| – | 60,611.8% | 29,285.9% | 0.5% | 12.6% | 9.8% | 9.7% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.